Aureobasidin A
Selleck Chemicals
SKU:E7319
Couldn't load pickup availability

Aureobasidin A is an anti-infective research compound relevant to immunology, inflammation, and infectious disease models. In practice, this places the compound in experiments that measure microbial and host-response phenotypes in immunology, inflammation, and infectious disease models.
Within the current annotation, Aureobasidin A is best positioned for anti-infective studies that monitor microbial growth responses, host-pathogen interactions, or related phenotype changes under controlled conditions. That positioning is consistent with microbial-response and host-pathogen phenotyping studies and with follow-up studies that compare concentration-dependent responses across orthogonal assay formats. In immunology, inflammation, and infectious disease models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Microbial-response and host-pathogen phenotyping studies
- Phenotypic profiling in immunology, inflammation, and infectious disease models
- Combination studies with orthogonal perturbagens
- Mechanism-oriented follow-up using biochemical and cellular endpoints
Overall, Aureobasidin A is appropriate for anti-infective, microbiology, and host-pathogen experiments in immunology, inflammation, and infectious disease models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Research Area:
- Immunology • Inflammation • Infectious Disease
- CAS No.:
- 127785-64-2
- Molecular Weight:
- 1101.42
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.